Spearheading Phage-based Solutions for Resistant Bacterial Infections

Established in 2018 with a registered capital of 80 million RMB, Shandong New Line Biotechnology Co., Ltd. (New Line) is a renowned scientific and technological enterprise dedicated to the research and development, cultivation, production, and sales of alternative and reduced resistance feed additive products.

In collaboration with Jiangsu Academy of Agricultural Sciences, we have established an innovation consortium that drives our pursuit of effective solutions to combat drug-resistant bacteria across diverse sectors such as animal husbandry and agriculture.Our International Phage R&D Center (IPRC), accessible at http://iprc.jaas.ac.cn/, serves as the cornerstone of our pioneering research efforts. With a distinguished team comprising over 30 PhDs and masters leading our scientific endeavors, we possess exceptional expertise in exploring the vast potential offered by phage biology.

To ensure comprehensive outcomes across various domains, we foster close collaborations with esteemed institutions including Chinese Academy of Sciences and CTC Bio Inc. from South Korea.Through harnessing phage biological solutions, our primary objective is resolute: to provide robust support for the prevention and control of bacterial infections within animal husbandry and agriculture sectors while effectively addressing the escalating issue of drug resistance.

At New Line, innovation propels us forward as we endeavor to safeguard public health while revolutionizing conventional approaches. Embark on this thrilling journey with us as we pave the way towards a brighter future devoid of resistant bacterial infections!